Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 6, 2014, Pages 728-731

  Berger, Joseph R ^a,b   Neltner, Janna ^a   Smith, Charles ^a   Cambi, Franca ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

JC virus; Neuromyelitis optica; Posterior reversible encephalopathy syndrome; Progressive multifocal leukoencephalopathy; Rituximab

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INTERFERON BETA SERINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; BRAIN BIOPSY; CASE REPORT; CONFUSION; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SINGLE DRUG DOSE; SYMPTOMATOLOGY; VISUAL DISORDER; WHITE MATTER LESION; BRAIN; CHEMICALLY INDUCED; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DRUG EFFECTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; NEUROMYELITIS OPTICA; PATHOLOGY; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84928028576     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2014.08.004     Document Type: Article

References (19)

1. Berger JR. Progressive multifocal leukoencephalopathy. In: Tselis A, editor. Neurovirology. Amsterdam: Elsevier; 2014. p. 1-20.
2. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998;4:59-68.
3. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 2013;80:1430-8.
4. Bergui M, Bradac GB, Oguz KK, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 2004;46:22-5.
5. Cheng C, Jiang Y, Chen X, et al. Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol 2013;13:72.
6. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427-32.
7. Haefner MD, Siciliano RD, Widmer LA, Vogel Wigger BM, Frick S. Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma. Onkologie 2007;30:138-40.
8. Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011;17:1107-12.
9. Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome- An underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006;33:2178-83.
10. Lee P, Plavina T, Castro A, et al. A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol 2013;57:141-6.
11. Magana SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009;72:712-7.
12. Martinez-Martinez MU, Abud-Mendoza C. Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab. Lupus 2012;21:1124-7.
13. Matiello M, Magana SM, Weinshenker BG. Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome. Neurology 2010;74:1478-9. (author reply 1479).
14. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leucoencepha- lopathy syndrome after rituximab infusion. Rheumatology 2004;43:1450-1.
15. Post MJ, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team Am J Neuroradiol 1999;20:1896-906.
16. Sanchez-Carteyron A, Alarcia R, Ara JR, Martin J. Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology 2010;74:1471-3.
17. Siddiqi AI. Rituximab as a possible cause of posterior reversible encephalopathy syndrome. Australas Med J 2011;4:513-5.
18. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012;72:779-87.
19. Zaheer F, Berger JR. Treatment related progressive multifocal leukoencephalopathy: current understanding and future steps. Ther Adv Drug Saf 2012;3:227-39.